Literature DB >> 25678236

Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.

Young-Min Lee1,2, Ji-Kyung Ha1, Je-Min Park1,2, Byung-Dae Lee1,2, EunSoo Moon1,2, Young-In Chung3, Ji-Hoon Kim3, Hak-Jin Kim4, Chi-Woong Mun5, Tae-Hyung Kim5, Young-Hoon Kim6.   

Abstract

OBJECTIVE: The aim of this study is to compare gray matter (GM) volume and white matter (WM) integrity in Apolipoprotein E4 (ApoE ε4) carriers with that of ApoE ε4 noncarriers using the voxel-based morphometry and diffusion tensor imaging (DTI) to investigate the effect of the ApoE ε4 on brain structures in subjective memory impairment (SMI) without white matter hyperintensities (WMH).
METHODS: Altogether, 26 participants with SMI without WMH were finally recruited from the Memory impairment clinics of Pusan National University Hospital in Korea. All participants were ApoE genotyped (ApoE ε4 carriers: n = 13, matched ApoE ε4 noncarriers: n = 13) and underwent 3-tesla magnetic resonance imaging (MRI) including 3-dimensional volumetric images for GM volume and DTI for WM integrity.
RESULTS: ApoE ε4 carriers compared with noncarriers in SMI without WMH showed the atrophy of GM in inferior temporal gyrus, inferior parietal lobule, anterior cingulum, middle frontal gyrus, and precentral gyrus and significantly lower fractional anisotropy WM values in the splenium of corpus callosum and anterior corona radiate.
CONCLUSION: Our findings suggest that the ApoE ε4 is associated with both atrophy of GM volume and disruption of WM integrity in SMI without WMH.
Copyright © 2015 by the American Society of Neuroimaging.

Entities:  

Keywords:  Apolipoprotein E4; gray matter volume; subjective memory impairment; white matter integrity

Mesh:

Substances:

Year:  2015        PMID: 25678236     DOI: 10.1111/jon.12207

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  6 in total

1.  APOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline.

Authors:  S Haller; M-L Montandon; C Rodriguez; M Ackermann; F R Herrmann; P Giannakopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

Review 2.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

3.  Right hippocampal volume mediation of subjective memory complaints differs by hypertension status in healthy aging.

Authors:  Emily J Van Etten; Pradyumna K Bharadwaj; Lauren A Nguyen; Georg A Hishaw; Theodore P Trouard; Gene E Alexander
Journal:  Neurobiol Aging       Date:  2020-06-19       Impact factor: 5.133

4.  Age-Related Differences in White Matter Integrity in Healthy Human Brain: Evidence from Structural MRI and Diffusion Tensor Imaging.

Authors:  Rishu Rathee; V P Subramanyam Rallabandi; Prasun K Roy
Journal:  Magn Reson Insights       Date:  2016-06-07

5.  Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohort.

Authors:  Virginie Dauphinot; Vincent Bouteloup; Jean-François Mangin; Bruno Vellas; Florence Pasquier; Frédéric Blanc; Olivier Hanon; Audrey Gabelle; Cédric Annweiler; Renaud David; Vincent Planche; Olivier Godefroy; Thérèse Rivasseau-Jonveaux; Marie Chupin; Clara Fischer; Geneviève Chêne; Carole Dufouil; Pierre Krolak-Salmon
Journal:  Alzheimers Dement (Amst)       Date:  2020-07-05

6.  Amyloid Load, Hippocampal Volume Loss, and Diffusion Tensor Imaging Changes in Early Phases of Brain Aging.

Authors:  Sven Haller; Marie-Louise Montandon; Cristelle Rodriguez; Valentina Garibotto; Johan Lilja; François R Herrmann; Panteleimon Giannakopoulos
Journal:  Front Neurosci       Date:  2019-11-15       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.